Syntaxis Company

Syntaxis is committed to discovering, developing and commercialising novel therapeutics that enhance recovery of brain functions after stroke.
Technology: NeuroTech
Industry: Biotechnology, Health Care, Science and Engineering
Headquarters: Lund, Skane Lan, Sweden
Founded Date: 2017-01-01
Employees Number: 1-10
Investors Number: 2
Total Funding: €200K
Estimated Revenue: Less than $1M
Last Funding Type: Seed

Visit Website
Register and Claim Ownership